Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients (Q43136745)
Jump to navigation
Jump to search
scientific article published in March 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients |
scientific article published in March 2010 |
Statements
1 reference
Switch from protease inhibitor- to efavirenz-based antiretroviral therapy improves quality of life, treatment satisfaction and adherence with low rates of virological failure in virologically suppressed patients (English)
1 reference
R E Campo
1 reference
C Cohen
1 reference
K Grimm
1 reference
T Shangguan
1 reference
J Maa
1 reference
D Seekins
1 reference
1 March 2010
1 reference
1 reference
21
1 reference
3
1 reference
166-171
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference